Edgewell Personal Care Company
NYSE:EPCHousehold & Personal Products
+$1.26 today
- Market cap
- $1.30B
- Beta
- 0.49
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$1.67
- Dividend yield
- 2.52%
Volume 0.50M
Average 0.79M
EPC Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Edgewell Personal Care CompanyNYSE: EPC
Financing Cash Flow · Q2 FY2026 · quarter ended Mar 2026
Financing cash flow growth accelerates
Q2 FY2026 financing cash flow of $300.8M (cash outflow) rose 704.3% year over year, ahead of the +468.2% change in trailing-twelve-month financing cash flow. Over 3 fiscal years it compounded at +19.5% a year.
Context
- Financing cash flow amounted to 1.3% of revenue in FY2025, down 6.6 pp from a year earlier.
- Financing cash flow grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +704.3% holds above the trailing-twelve-month pace of +468.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (30M) USD
- Year-over-year change
- +83.3%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | (30M) | +83.3% |
| FY2024 | 2024-09-30 | (179.4M) | -22.5% |
| FY2023 | 2023-09-30 | (146.5M) | -732.4% |
| FY2022 | 2022-09-30 | (17.6M) | +73.1% |
| FY2021 | 2021-09-30 | (65.4M) | — |
Financing Cash Flow vs competitors
How EPC compares with its peers on the latest reported figures
- EPC's LTM Mar 2026 financing cash flow of $269.9M is the largest of the 9 companies compared; the peer median is $54.2M.
- Its year-over-year change of +468.2% is the highest of 9, against a peer median of -47.7%.
- Financing cash flow amounts to 12.8% of revenue for EPC, versus a peer median of 4.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $269.9M | +468.2% | +19.5% | 12.8% | |
| LTM Mar 2026 | $221.3M | -11.2% | +3.7% | 4.3% | |
| LTM Jun 2026 | $154M | -40.6% | — | 5.4% | |
| LTM Mar 2026 | $118.57M | -54.8% | — | 7.1% | |
| LTM Mar 2026 | $56.51M | -78.9% | +26.7% | 3.9% | |
| LTM Mar 2026 | $51.88M | +65.0% | -7.3% | 3.9% | |
| LTM Mar 2026 | $50.4M | -353.7% | — | 4.3% | |
| LTM Mar 2026 | $47.56M | -206.8% | -12.8% | 3.3% | |
| LTM Apr 2026 | $38.1M | +19.1% | +10.6% | 3.1% | |
| Peer median (excluding EPC) | $54.2M | -47.7% | +3.7% | 4.1% | |
Competitors are the stored peer set for EPC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Net Income | 117.8M | 99.5M | 114.7M | 98.6M | 25.4M |
| Depreciation & Amortization | 87.1M | 89.9M | 91.4M | 88M | 88.8M |
| Deferred Income Tax | 9.6M | (13.7M) | (4.5M) | (9.6M) | (21.7M) |
| Stock-Based Compensation | 27.3M | 23.8M | 27.5M | 26.5M | 24.5M |
| Change in Working Capital | (28M) | (82.1M) | 5M | 47.6M | (25.8M) |
| Accounts Receivables | 3.7M | (6.6M) | 31M | (7.3M) | (15.3M) |
| Inventory | (28.8M) | (111.3M) | (32.4M) | 19.7M | 100K |
| Accounts Payables | 24.3M | 29.3M | (30.2M) | 17M | 3.3M |
| Other Working Capital | (27.2M) | 6.5M | 36.6M | 18.2M | (13.9M) |
| Other Non-Cash Items | 15.2M | (15.4M) | (18M) | (20.1M) | 27.2M |
| Operating Cash Flow | 229M | 102M | 216.1M | 231M | 118.4M |
| Capital Expenditures | (56.8M) | (56.4M) | (49.5M) | (56.5M) | (77M) |
| Acquisitions (Net) | 7.2M | (304.4M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 900K | 5.4M | (1M) | (5.9M) | 4.1M |
| Investing Cash Flow | (48.7M) | (355.4M) | (50.5M) | (62.4M) | (72.9M) |
| Debt Repayment | (21.9M) | 151.1M | (33M) | (83.8M) | 111.5M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (9.2M) | (125.3M) | (75.2M) | (58.5M) | (90.2M) |
| Dividends Paid | (25.6M) | (32.6M) | (31.5M) | (30.7M) | (29.3M) |
| Other Financing Activities | (8.7M) | (10.8M) | (6.8M) | (6.4M) | (22M) |
| Financing Cash Flow | (65.4M) | (17.6M) | (146.5M) | (179.4M) | (30M) |
| Effect of Forex Changes | (400K) | (19.5M) | 8.6M | 3.5M | 1.1M |
| Net Change in Cash | 114.5M | (290.5M) | 27.7M | (7.3M) | 16.6M |
| Free Cash Flow | 172.2M | 45.6M | 166.6M | 174.5M | 41.4M |
Edgewell Personal Care Company
NYSE:EPC
Intrinsic Alpha fair value
Locked
Current Price
$28.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.